Otolaryngology · Fitchburg, MA
NPI
1265429617
Since 2005
Specialty
Otolaryngology
Code 207Y00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
33 Electric Ave
Fitchburg, MA, 01420
Phone (978) 342-1200
Medicare paid, 2022
$3,021
61 services
Medicare patients, 2022
49
Average age 75
Drug cost, 2024
$38.5M
182,670 prescriptions
Company payments, 2024
$200
From 1 companies
Procedures and visits billed to Original Medicare, 2022
In 2022, the most common Medicare service billed by John R Bogdasarian was code 99213 (office e&m - established), 40 times for 38 patients. In total John R Bogdasarian billed 61 services in 5 codes, and Medicare paid $3,021.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 40 | 38 | $54.80 | $2,192 |
Medicare prescription drug claims, 2024
In 2024, the drug John R Bogdasarian prescribed most often to Medicare patients was Shingrix (Varicella-Zoster Ge/As01b/Pf), with 68,326 prescriptions and refills. In total John R Bogdasarian wrote 182,670 Medicare prescriptions that cost $38.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Shingrix Varicella-Zoster Ge/As01b/Pf | 68,326 | 68,420 | 51,669 | $13.2M |
| Arexvy Rsvpref3 Antigen/As01e/Pf | 56,818 | 56,910 | 56,583 | $15.9M |
| Boostrix Tdap Diphth,pertuss(Acell),tet Vac | 26,866 | 26,930 | 26,757 | $1.7M |
| Abrysvo Rsv Vacc, Pref A And Pref B/Pf | 24,213 | 24,233 | 24,159 | $6.9M |
| Twinrix Hepatitis A And B Vaccine/Pf | 2,346 | 2,348 | 1,449 | $306K |
| Havrix Hepatitis A Virus Vaccine/Pf | 827 | 829 | 765 | $79K |
| Mresvia Rsv Vaccine, Pref, Mrna/Pf | 806 | 806 | 805 | $242K |
| Adacel Tdap Diph,pertuss(Acell),tet Vac/Pf | 552 | 552 | 550 | $33K |
| Tenivac Tetanus-Diphtheria Toxoids/Pf | 504 | 504 | 504 | $27K |
| Heplisav-B Hepatitis B Vaccine/Cpg1018/Pf | 324 | 324 | 220 | $50K |
| M-M-R Ii Vaccine Measles,mumps,rubella Vacc/Pf | 265 | 265 | 248 | $27K |
| Gardasil 9 Hpv Vaccine 9-Valent/Pf | 154 | 154 | 119 | $40K |
| Menquadfi Mening Vac A,c,y,w135,c-Tet/Pf | 121 | 121 | 115 | $20K |
| Priorix Measles,mumps,rubella Vacc/Pf | 100 | 100 | 90 | $10K |
| Tdvax Tetanus, Diphtheria Tox,adult | 64 | 64 | 64 | $2,890 |
Brand drugs: 182,602 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid John R Bogdasarian $200 ($200 in general payments such as food, travel and fees) from 1 company. The largest payer was Cardinal Health 110 LLC with $200.
| Company | Payments | Amount |
|---|---|---|
| Cardinal Health 110 LLC | 1 | $200 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.